A microneedle patch for measles and rubella vaccination: a game changer for achieving elimination.
Curr Opin Virol
; 41: 68-76, 2020 04.
Article
de En
| MEDLINE
| ID: mdl-32622318
ABSTRACT
While morbidity and mortality associated with measles and rubella (MR) have dramatically decreased, there are still >100000 estimated deaths due to measles and an estimated 100000 infants born with congenital rubella syndrome annually. Given highly effective MR vaccines, the primary barrier to global elimination of these diseases is low vaccination coverage, especially among the most underserved populations in resource-limited settings. In contrast to conventional MR vaccination by hypodermic injection, microneedle patches are being developed to enable MR vaccination by minimally trained personnel. Simplified supply chain, reduced need for cold chain storage, elimination of vaccine reconstitution, no sharps waste, reduced vaccine wastage, and reduced total system cost of vaccination are advantages of this approach. Preclinical work to develop a MR vaccine patch has proceeded through successful immunization studies in rodents and non-human primates. On-going programs seek to make MR vaccine patches available to support MR elimination efforts around the world.
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Rubéole
/
Vaccin contre la rougeole
/
Vaccin antirubéoleux
/
Vaccination
/
Rougeole
Limites:
Animals
/
Humans
Langue:
En
Journal:
Curr Opin Virol
Année:
2020
Type de document:
Article